Cellosaurus logo
expasy logo

Cellosaurus Ramos (CVCL_0597)

[Text version]
Cell line name Ramos
Synonyms RAMOS; Ramos 1; RA 1; RA.1; Ra #1; Ra No. 1; Ramos(RA1); Ramos-RA1; Ramos (RA 1); Ramos (RA #1); Ramos (RA)
Accession CVCL_0597
Resource Identification Initiative To cite this cell line use: Ramos (RRID:CVCL_0597)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: LL-100 blood cancer cell line panel.
Part of: MD Anderson Cell Lines Project.
Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
Population: Caucasian.
Virology: EBV-negative.
Doubling time: 20.4 +- 1.5 hours (PubMed=9225077); 23 hours (PubMed=8402660); 26 hours (PubMed=9563901); 14 hours (PubMed=20922763); ~48 hours (DSMZ=ACC-603).
Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
Omics: Genomics; Whole exome sequencing.
Omics: Proteomics.
Omics: Proteomics; Expression; Reverse-phase protein array.
Omics: Transcriptomics; Microarray.
Omics: Transcriptomics; RNAseq.
Omics: Variations; SNP array analysis.
Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
Cell type: B-cell; CL=CL_0000236.
Sequence variations
HLA typing Source: PubMed=25960936
Class I
HLA-AA*03:01,03:01
HLA-BB*44:03,51:01
HLA-CC*16:01,16:01
Class II
HLA-DQDQA1*02:01,02:01
DQB1*02:01,02:01
HLA-DRDRB1*07:01,14:103

Source: PubMed=26589293
Class I
HLA-AA*03:01,03:01
HLA-BB*44:03,51:01
HLA-CC*16:01,16:01
Class II
HLA-DQDQA1*02:01,02:01
DQB1*02:01,02:01
HLA-DRDRB1*07:01,14:05

Source: CLS=302007
Class I
HLA-AA*03:01:01
HLA-BB*44:160Q,51:01:01
HLA-CC*16:01:01
Class II
HLA-DPDPB1*04:01:01,104:01:01
HLA-DQDQA1*02:01:01
DQB1*02:02:01
HLA-DRDRB1*07:01:01

Source: DSMZCellDive=ACC-603
Class I
HLA-AA*03:01:01,03:01:01
HLA-BB*44:03:01,51:01:01
HLA-CC*16:01:01,16:01:01
Class II
HLA-DPDPA1*01:03:01,01:03:01
DPB1*04:01:01,104:01
HLA-DQDQA1*02:01:01,02:01:01
HLA-DRDRA*01:01:01,01:01:01
DRB1*07:01:01,07:01:01
Disease Burkitt lymphoma (NCIt: C2912)
Burkitt lymphoma (ORDO: Orphanet_543)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_KS64 (CellSensor ISRE-bla RA-1)CVCL_KS46 (CellSensor NFAT-bla RA-1)CVCL_KB47 (CellSensor NFkB-bla RA-1)
CVCL_KS55 (CellSensor STAT6-bla RA-1)CVCL_E1MG (HyCyte Ramos KO-hIRF1)CVCL_E1MH (HyCyte Ramos KO-hSH3KBP1)
CVCL_E1MI (HyCyte Ramos KO-hWAS)CVCL_B6UL (II-WA-Ramos)CVCL_JL65 (Ramos B7)
CVCL_2702 (Ramos-AW)CVCL_X591 (Ramos-Blue)CVCL_X592 (Ramos-Blue KD-Myd)
CVCL_C003 (Ramos-EHRA)CVCL_2703 (Ramos-EHRB)CVCL_1646 (Ramos.2G6.4C10)
CVCL_ZU79 (Ramos/B95-8)CVCL_S546 (Ramos/DC-SIGN)CVCL_ZU80 (Ramos/NPC)
CVCL_WS53 (sfRamos)
Sex of cell Male
Age at sampling 3Y
Category Cancer cell line
STR profile Source(s): ATCC=CRL-1596; CCRID; CLS=302007; COG; DepMap=ACH-001636; DSMZ=ACC-603; ECACC=85030802; JCRB=JCRB9119; KCLB=21596; PubMed=20922763; PubMed=25877200; Technion Genomics Center

Markers:
AmelogeninX
CSF1PO10,11
D1S165612,15.3
D2S44111,14
D2S133820,23
D3S135814,15
D5S8187,12
D6S104313,15
D7S82011
D8S117913 (CLS=302007)
13,16 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; DSMZ=ACC-603; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
D10S124814,15
D12S39119,22
D13S31712,13,14 (CLS=302007)
13,14 (ATCC=CRL-1596; CCRID; COG; DepMap=ACH-001636; DSMZ=ACC-603; ECACC=85030802; JCRB=JCRB9119; KCLB=21596; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
D16S53910,13
D18S5114,15 (CLS=302007; DSMZ=ACC-603)
15 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
D19S43314,15.2
D21S1130
D22S104515
FGA20,24
Penta D10,13
Penta E6,8,21 (CLS=302007)
8,21 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; DSMZ=ACC-603; PubMed=25877200; Technion Genomics Center)
TH017,9.3
TPOX8,9
vWA15,16

Run an STR similarity search on this cell line
Web pages Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Ramos
Info; MCLP; -; https://tcpaportal.org/mclp/
Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-485.html
Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/ramos-xenograft-model/
Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
Publications

PubMed=181343; DOI=10.1159/000149930
George Klein, Beppino Carlo Giovanella, Anita Westman, John Sebastian Stehlin Jr., David Meday Mumford;
An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Intervirology 5:319-334(1975)

PubMed=62724; DOI=10.1002/ijc.2910180513
George Klein, Jesper Zeuthen, Paul Ichiro Terasaki, Ronald James Billing, Ron Honig, Mikael Jondal, Anita Westman, Geoffrey Baverstock Clements;
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Int. J. Cancer 18:639-652(1976)

PubMed=175026; DOI=10.1002/ijc.2910170203
Karl-Otto Fresen, Harald zur Hausen;
Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Int. J. Cancer 17:161-166(1976)

PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x
Susan Povey, Stephen Jeremiah, Elizabeth Arthur, Michael Steel, George Klein;
Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.
Ann. Hum. Genet. 44:119-133(1980)

PubMed=6286763; DOI=10.4049/jimmunol.129.3.1336
David Benjamin, Ian Trevor Magrath, Robert T. Maguire, Carol Janus, Heather D. Todd-Kulikowsk, Robert G. Parsons;
Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.
J. Immunol. 129:1336-1342(1982)

PubMed=6231253; DOI=10.1002/ijc.2910330407
Barbro Ehlin-Henriksson, George Klein;
Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation.
Int. J. Cancer 33:459-463(1984)

PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0
Hans Gunther Drexler, Gerhard Gaedicke, Jun Minowada;
Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 Carboxylic esterase.
Leuk. Res. 9:209-229(1985)

PubMed=2998993
Christopher Michael Steel, John E.N. Morten, E. Foster;
The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
IARC Sci. Publ. 60:265-292(1985)

PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1
Hans Gunther Drexler, Gerhard Gaedicke, Jun Minowada;
Isoenzyme studies in human leukemia-lymphoma cell lines -- III Beta-hexosaminidase (E.C. 3.2.1.30).
Leuk. Res. 9:549-559(1985)

PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x
Hans Gunther Drexler, Gerhard Gaedicke, Jun Minowada;
Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid phosphatase.
Leuk. Res. 9:537-548(1985)

PubMed=3518877; DOI=10.3109/07357908609038260
Jorgen Fogh;
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=2835030; DOI=10.1016/S0385-8146(87)80025-1
Toru Takimoto, Hiroshi Sato, Hisashi Ogura, Tameo Miyazaki;
Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
Auris Nasus Larynx 14:87-92(1987)

PubMed=3026973; DOI=10.1002/ijc.2910390215
Barbro Ehlin-Henriksson, Agneta Manneborg-Sandlund, George Klein;
Expression of B-cell-specific markers in different Burkitt lymphoma subgroups.
Int. J. Cancer 39:211-218(1987)

PubMed=1850347; DOI=10.1210/endo-128-5-2266
Laurel Ann Baglia, Daniel Cruz, James E. Shaw;
An Epstein-Barr virus-negative Burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continuous growth in serum-free medium.
Endocrinology 128:2266-2272(1991)

PubMed=1915267; DOI=10.1002/j.1460-2075.1991.tb07837.x; PMCID=PMC452998
Paul J. Farrell, Gordon J. Allan, Frances Shanahan, Karen Heather Vousden, Tim Crook;
p53 is frequently mutated in Burkitt's lymphoma cell lines.
EMBO J. 10:2879-2887(1991)

PubMed=2052620; DOI=10.1073/pnas.88.12.5413; PMCID=PMC51883
Gianluca Gaidano, Paola Ballerini, Jerry Z. Gong, Giorgio Inghirami, Antonino Neri, Elizabeth W. Newcomb, Ian Trevor Magrath, Daniel M. Knowles, Riccardo Dalla-Favera;
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Proc. Natl. Acad. Sci. U.S.A. 88:5413-5417(1991)

PubMed=8316623; DOI=10.2307/3578190
Helen Harrington Evans, Marlene Ricanati, Min-Fen Horng, Qiao-Yun Jiang, Jaroslav Mencl, Peggy Louise Olive;
DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines.
Radiat. Res. 134:307-315(1993)

PubMed=8344493; DOI=10.1096/fasebj.7.10.8344493
Kishor G. Bhatia, Walter Goldschmidts, Marina I. Gutierrez, Gianluca Gaidano, Riccardo Dalla-Favera, Ian Trevor Magrath;
Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
FASEB J. 7:951-956(1993)

PubMed=8402660
Patrick M. O'Connor, Joany Jackman, Daniel Jondle, Kishor G. Bhatia, Ian Trevor Magrath, Kurt W. Kohn;
Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
Cancer Res. 53:4776-4780(1993)

PubMed=8515068; DOI=10.4049/jimmunol.150.12.5418
Vinay K. Jain, Jean-Gabriel Judde, Edward E. Max, Ian Trevor Magrath;
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
J. Immunol. 150:5418-5428(1993)

PubMed=7757991
Insoo Bae, Sai-Jun Fan, Kishor G. Bhatia, Kurt W. Kohn, Albert J. Fornace Jr., Patrick M. O'Connor;
Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
Cancer Res. 55:2387-2393(1995)

PubMed=8896424; DOI=10.1182/blood.V88.9.3562.bloodjournal8893562
Caroline J. Chapman, Jo X. Zhou, Christopher D. Gregory, Alan Bernard Rickinson, Freda K. Stevenson;
VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection.
Blood 88:3562-3568(1996)

PubMed=9192833
Barry W. Cherney, Kishor G. Bhatia, Cecilia Sgadari, Marina I. Gutierrez, Howard S. Mostowski, Sandra E. Pike, Ghanshyam Gupta, Ian Trevor Magrath, Giovanna Tosato;
Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Cancer Res. 57:2508-2515(1997)

PubMed=9225077; DOI=10.1016/S0145-2126(97)00126-4
Motohiko Okano;
High susceptibility of an Epstein-Barr virus-converted Burkitt's lymphoma cell line to cytotoxic drugs.
Leuk. Res. 21:469-471(1997)

PubMed=9473234; DOI=10.1182/blood.V91.5.1680
Ulf Klangby, Ismail Okan, Kristinn Petur Magnusson, Martin Wendland, Peter Lind, Klas G. Wiman;
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood 91:1680-1687(1998)

PubMed=9563901
Sai-Jun Fan, Barry W. Cherney, William C. Reinhold, Kimberly Rucker, Patrick M. O'Connor;
Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
Clin. Cancer Res. 4:1047-1054(1998)

PubMed=9973220
Marina I. Gutierrez, Barry W. Cherney, Azhar Hussain, Howard S. Mostowski, Giovanna Tosato, Ian Trevor Magrath, Kishor G. Bhatia;
Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
Cancer Res. 59:696-703(1999)

PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4
Kaoru Inoue, Takashi Kohno, Satoshi Takakura, Yasuhide Hayashi, Hideaki Mizoguchi, Jun Yokota;
Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines.
Leuk. Res. 24:255-262(2000)

PubMed=10918597; DOI=10.1038/sj.onc.1203686
Mats Bemark, Michael Samuel Neuberger;
The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Oncogene 19:3404-3410(2000)

PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1
Kaoru Inoue, Takashi Kohno, Satoshi Takakura, Yasuhide Hayashi, Hideaki Mizoguchi, Jun Yokota;
Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000), 255-262.
Leuk. Res. 25:275-278(2001)

PubMed=12967475; DOI=10.1111/j.1349-7006.2003.tb01518.x; PMCID=PMC11160262
Yoshitomo Maesako, Takashi Uchiyama, Hitoshi Ohno;
Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
Cancer Sci. 94:774-781(2003)

PubMed=18211290; DOI=10.1111/j.1365-2184.2007.00500.x; PMCID=PMC6495949
Linda Zander Balderud, Mats Bemark;
Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line.
Cell Prolif. 41:136-155(2008)

PubMed=20922763; DOI=10.1002/pbc.22801; PMCID=PMC3005554
Min H. Kang, Malcolm A. Smith, Christopher L. Morton, Nino Keshelava, Peter J. Houghton, Charles Patrick Reynolds;
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.
Pediatr. Blood Cancer 56:239-249(2011)

PubMed=22885699; DOI=10.1038/nature11378; PMCID=PMC3609867
Roland Schmitz, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wen-Ming Xiao, Mei-Li Zhang, George Wright, Arthur L. Shaffer 3rd, Daniel James Hodson, Eric Buras, Xue-Lu Liu ...Show all 42 authors... , John I. Powell, Yan-Dan Yang, Wei-Hong Xu, Hong Zhao, Holger Kohlhammer, Andreas Rosenwald, Philip M. Kluin, Hans-Konrad Muller-Hermelink, German Ott, Randy D. Gascoyne, Joseph M. Connors, Lisa M. Rimsza, Elias Campo, Elaine Sarkin Jaffe, Jan Delabie, Erlend Bremertun Smeland, Martin David Ogwang, Steven J. Reynolds, Richard I. Fisher, Rita Merle Braziel, Raymond Roy Tubbs, James R. Cook, Dennis D. Weisenburger, Wing-Chung Chan, Stefania Pittaluga, Wesley Wilson, Thomas Alexander Waldmann, Martin Rowe, Sam M. Mbulaiteye, Alan Bernard Rickinson, Louis Michael Staudt; Show fewer authors
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Nature 490:116-120(2012)

PubMed=24590883; DOI=10.1002/gcc.22161
Eva-Maria Murga Penas, Georgia Schilling, Petra Behrmann, Marianne Klokow, Eik Vettorazzi, Carsten Bokemeyer, Judith Dierlamm;
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Genes Chromosomes Cancer 53:497-515(2014)

PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981
Sebastian Boegel, Martin Lower, Thomas Bukur, Ugur Sahin, John C. Castle;
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=25485619; DOI=10.1038/nbt.3080
Christiaan Klijn, Steffen Durinck, Eric W. Stawiski, Peter M. Haverty, Zhao-Shi Jiang, Han-Bin Liu, Jeremiah Degenhardt, Oleg Mayba, Florian Gnad, Jin-Feng Liu, Gregoire Pau ...Show all 30 authors... , Jens Reeder, Yi Cao, Kiran Mukhyala, Suresh K. Selvaraj, Ma-Mie Yu, Gregory J. Zynda, Matthew J. Brauer, Thomas D. Wu, Robert Clifford Gentleman, Gerard Manning, Robert L. Yauch, Richard Bourgon, David Stokoe, Zora Modrusan, Richard M. Neve, Frederic J. de Sauvage, Jeffrey Settleman, Somasekar Seshagiri, Ze-Min Zhang; Show fewer authors
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25877200; DOI=10.1038/nature14397
Ma-Mie Yu, Suresh K. Selvaraj, May M.Y. Liang-Chu, Sahar Aghajani, Matthew Busse, Jean Yuan, Genee Lee, Franklin V. Peale, Christiaan Klijn, Richard Bourgon, Joshua S. Kaminker, Richard M. Neve;
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878
Jelle Scholtalbers, Sebastian Boegel, Thomas Bukur, Marius Byl, Sebastian Goerges, Patrick Sorn, Martin Loewer, Ugur Sahin, John C. Castle;
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome Med. 7:118.1-118.7(2015)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Jun Li, Wei Zhao, Rehan Akbani, Wen-Bin Liu, Zhen-Lin Ju, Shi-Yun Ling, Christopher P. Vellano, Paul Roebuck, Qing-Hua Yu, A. Karina Eterovic, Lauren Averett Byers ...Show all 25 authors... , Michael A. Davies, Wan-Leng Deng, Y.N. Vashisht Gopal, Guo Chen, Erika Maria von Euw, Dennis Joseph Slamon, Dylan Conklin, John Victor Heymach, Adi F. Gazdar, John D. Minna, Jeffrey N. Myers, Yi-Ling Lu, Gordon B. Mills, Han Liang; Show fewer authors
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646
Hilmar Quentmeier, Claudia Pommerenke, Wilhelm Gerhard Dirks, Sonja Eberth, Max Koeppel, Roderick A.F. MacLeod, Stefan Nagel, Klaus G. Steube, Cord C. Uphoff, Hans Gunther Drexler;
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218.1-8218.14(2019)

Cross-references
Cell line collections (Providers) ATCC; CRL-1596
BCRC; 60252
BEI_Resources; ARP-9938
CLS; 302007
DSMZ; ACC-603
ECACC; 85030802
ECACC; 91030710
JCRB; JCRB9119
KCLB; 21596
NCBI_Iran; C128
Cell line databases/resources CLO; CLO_0008738
CLO; CLO_0008739
MCCL; MCC:0000410
CLDB; cl4096
CLDB; cl4097
CLDB; cl4098
cancercelllines; CVCL_0597
CCRID; 1101HUM-PUMC000048
CCRID; 1102HUM-NIFDC00052
Cell_Model_Passport; SIDM01094
CGH-DB; 9205-4
DepMap; ACH-001636
DSMZCellDive; ACC-603
FCS-free; 243-2-490-3-4-12
LINCS_HMS; 50811
LINCS_LDP; LCL-1097
Lonza; 725
Anatomy/cell type resources BTO; BTO_0003079
Biological sample resources BioSample; SAMN01821590
BioSample; SAMN01821657
BioSample; SAMN03472718
CRISP screens repositories BioGRID_ORCS_Cell_line; 151
Chemistry resources ChEMBL-Cells; CHEMBL3307664
ChEMBL-Targets; CHEMBL614629
PharmacoDB; RAMOS_1283_2019
PubChem_Cell_line; CVCL_0597
Encyclopedic resources Wikidata; Q54949198
Experimental variables resources EFO; EFO_0002077
Gene expression databases ArrayExpress; E-MTAB-2706
ArrayExpress; E-MTAB-7721
ArrayExpress; E-MTAB-7722
GEO; GSM99388
GEO; GSM987747
GEO; GSM987748
GEO; GSM987749
GEO; GSM1374843
GEO; GSM1374844
GEO; GSM3150254
Polymorphism and mutation databases Cosmic; 929817
Cosmic; 931111
Cosmic; 991547
Cosmic; 998719
Cosmic; 1037704
Cosmic; 1226864
Cosmic; 1509204
Cosmic; 1517660
Cosmic; 1762459
Cosmic; 1818347
Cosmic; 2750875
Cosmic; 2759408
Cosmic; 2814542
Cosmic; 2823075
IARC_TP53; 180
Proteomic databases PRIDE; PXD000447
PRIDE; PXD012087
Sequence databases EGA; EGAS00001000610
Entry history
Entry creation04-Apr-2012
Last entry update10-Apr-2025
Version number45